Despite the slightly warmer weather and longer periods of sunshine, we are still in the depths of cold and flu season, a ...

Nirsevimab is protective against RSV infections and coinfections, which suggests there is no replacement of RSV with other viruses post-nirsevimab administration.

New figures show the number of babies admitted to hospital with respiratory viruses has trebled in just a year, according to Manx Care.

It spreads through inhalation or contact with the fluids from an infected person's coughs or sneezes. 2 While often linked to ...

In the wake of multiple cases of human metapneumovirus (hMPV) in India, multiple questions about its causes and symptoms seem ...

Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infections in children under two years old, resulting in significant morbidity and a heavy economic burden on healthcare ...

With respiratory illness season at its peak, the latest CDC data shows a significant rise in flu cases nationwide, while COVID-19 cases decline and RSV activity continues to wane. According to the CDC ...

7. New RSV prevention options for infants and pregnant mothers A new RSV prevention option for infants was introduced in 2023: the monoclonal antibody treatment Beyfortus (nirsevimab). This shot is ...

A new study is showing a policy change in 2016 related to the vaccination of some premature babies for RSV in Nova Scotia led to a tenfold increase in the number of infants in that group that ...